The Pharmalot blog reports today on a Reuter's story about an oral vaccine for Alzheimer's that proved successful at diminishing signs of Alzheimer's in a study of 28 mice bred to develop the disease. Limited testing of the vaccine in humans may be next.
The vaccine works by reducing the amount of amyloid plaques in the brains of the diseased mice, visibly improving their cognitive function. "In other words," writes Ed Silverman at Pharmalot, "[the mice] could find their way to the kitchen counter again."
- Log in to post comments
More like this
Alzheimer's Disease is the most common form of age-related dementia, affecting an estimated 25 million people worldwide.The pathological hallmarks of this condition, which were described 100 years ago by the German pathologist Alois Alzheimer, consist of plaques of amyloid beta protein and…
We all know that inhaled anesthesia is over the short-term impairs neurological function; that is sort of the point using it for surgery.
However, a debate exists about whether inhaled anesthetics have long-term neurological consequences as well. In light of that debate Bianchi et al, publishing…
Yet another cell phone and disease story, and while this one is on the "good news" side, it doesn't reassure me:
The millions of people who spend hours every day on a cell phone, may have a new excuse for yakking. A surprising new study in mice provides the first evidence that long-term exposure to…
You look away from a field for two seconds, and they get all crazy on you... I used to do only molecular biology focusing primarily on neurodegenerative diseases like Alzheimer's. Since I moved to a lab that studies behavior, I haven't been keeping up with the literature of Alzheimer's as much…